KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,294 | -15.9% | 9,062 | +7.9% | 0.01% | -13.3% |
| Q2 2023 | $1,821,106 | +25.9% | 8,398 | +5.4% | 0.02% | +15.4% |
| Q1 2023 | $1,446,763 | -2.5% | 7,965 | +5.5% | 0.01% | -7.1% |
| Q4 2022 | $1,483,379 | -9.1% | 7,549 | +4.1% | 0.01% | -17.6% |
| Q3 2022 | $1,632,000 | +112.8% | 7,255 | +19.7% | 0.02% | +142.9% |
| Q2 2022 | $767,000 | +7.9% | 6,059 | +8.1% | 0.01% | +16.7% |
| Q1 2022 | $711,000 | -2.5% | 5,605 | +0.7% | 0.01% | 0.0% |
| Q4 2021 | $729,000 | +6.1% | 5,568 | -0.9% | 0.01% | 0.0% |
| Q3 2021 | $687,000 | +17.2% | 5,617 | +9.3% | 0.01% | +20.0% |
| Q2 2021 | $586,000 | +38.9% | 5,141 | +46.4% | 0.01% | +25.0% |
| Q1 2021 | $422,000 | +19.5% | 3,512 | +1.1% | 0.00% | +33.3% |
| Q4 2020 | $353,000 | +28.8% | 3,473 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $274,000 | -7.1% | 3,548 | +33.9% | 0.00% | -25.0% |
| Q2 2020 | $295,000 | – | 2,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |